Sellas Life Sciences Shares Post Worst Week in Over a Month

Sellas Life Sciences shares closed Friday at $9.98 after falling nearly 12%, their worst week in over a month. Some retail investors speculated that results from its REGAL trial may be under wraps ahead of a hematology conference.